Skip to main content

Return to Previous Page

2019 Clinical Scientist Development Award

Awarded: Jul 01, 2019

$495,000 over 3 years

In 2019, 16 physician scientists received three-year grants of $495,000 each to support their transition to independent clinical research careers.

2019 CSDA Grantees

Giada Bianchi, M.D.
Dana-Farber Cancer Institute
Project name: Uncovering the Oncogenic Role of Ubiquitin Depletion During B Lymphocyte Differentiation

Philip J. Budge, M.D., Ph.D.
Washington University School of Medicine in St. Louis
Project name: Cross-Reactive Antigenemia and Treatment-Related Adverse Events in Loiasis

Jasmeer P. Chhatwal, M.D., Ph.D.
Massachusetts General Hospital, Harvard Medical School
Project name: Sleep Disruption as a Driver of Neuronal Dysfunction and Tau Accumulation in Preclinical Alzheimer's Disease

Brian J. DeBosch, M.D., Ph.D.
Washington University School of Medicine in St. Louis
Project name: Modeling Human Hepatocytes to Translate Glucose-Fasting Mimetics as Novel Therapies Against Non-Alcoholic Fatty Liver Disease

Kathryn M. Dupnik, M.D.
Weill Cornell Medicine
Project name: Dynamics of the HIV Reservoir and Mycobacterium tuberculosis Burden in People with HIV-TB Coinfection

Jennifer A. Fulcher, M.D., Ph.D.
University of California Los Angeles
Project name: Mechanisms of Intestinal Dysbiosis and Inflammation in Substance Use and HIV

Daniel S. Herman, M.D., Ph.D.
Perelman School of Medicine at the University of Pennsylvania
Project name: Development and Implementation of Statistical Methods and Informatics Tools that Leverage Clinical Data for Decision Support to Improve Screening for Primary Aldosteronism

Andrew L. Kau, M.D., Ph.D.
Washington University School of Medicine in St. Louis
Project name: Role of Anti-FimH Antibodies in Modulating Uropathogenic E. coli Gut Colonization and Urinary Tract Infection

Michelle T. Long, M.D., M.Sc.
Boston University
Project name: Resting Metabolic Signature of Non-Alcoholic Fatty Liver Disease and the Metabolic Response to Acute Exercise in a Community Based Sample

Deepak A. Rao, M.D., Ph.D.
Brigham and Women's Hospital
Project name: Cellular Immunophenotypes to Predict Treatment Response in Rheumatoid Arthritis

Bryan K. Sun, M.D., Ph.D.
University of California at San Diego
Project name: Noncoding Genetic Regulators of Skin Diseases

Zuzana Tothova, M.D., Ph.D.
Dana-Farber Cancer Institute
Project name: Therapeutic Targeting of Splicing in Cohesin Mutant Myeloid Malignancies

Adina F. Turcu, M.D., M.S.
University of Michigan
Project name: Developing Tools for Personalized Care of Patients with Primary Aldosteronism

Silvia Vilarinho, M.D., Ph.D.
Yale School of Medicine
Project name: Genetics and Pathogenesis of Cholestatic Liver Disease

Jesse J. Waggoner, M.D.
Emory University School of Medicine
Project name: Arboviral Antibody Signatures on a Nanoscale Plasmonic Gold Platform to Predict Severe Dengue in Symptomatic Cases

Frederick Wilson, M.D., Ph.D.
Yale School of Medicine
Project name: Combination Strategies to Enhance the Efficacy of Targeted Therapies

Visit Site